TBVAC2020: Advancing tuberculosis vaccines from discovery to clinical development

Nadia Rosalia Caccamo, Etienne Caron, Krista Van Meijgaarden, Natalie Nieuwenhuizen, Morten Ruhwald, Sung Jae Shin, Claudio Counoupas, Marta Romano, Nicolas Collin, Elena Stylianou, Jayne Sutherland, Ann Williams, Peter Andersen, Yvonne Perrie, Tom H. M. Ottenhoff, Ruedi Aebersold, Christophe Barnier-Quer, Pere-Joan Cardona, Dessi Marinova, Myrsini KaforouStephanie Kallert, Rachel Tanner, Mariateresa Coppola, Jeroen Maertzdorf, Nacho Aguilo, Genevieve Inchauspe, Dennis Christensen, Thomas Lindenstrom, Gerhard Walzl, Mei Mei Ho, Marc Baird, Hazel M. Dockrell, Hyejon Lee, Hermann Giresse Tima, Helen Fletcher, Frank A. W. Verreck, Ino Choi, Nick Drager, Brij Patel, Marie-Ange Demoitie, Stephane Leung Theung Long, François Spertini, Steven Smith, Thomas Scriba, Cris Vilaplana, Iman Satti, Simone Joosten, Claus Aagaard, Nadia Caccamo, Martin Vordermeier, Daniel Pinschewer, Isabelle Vergne, Francoise Mascart, Frank Verreck, Alex Sigal, Olivier Neyrolles, Christophe Guilhot, Danilo Casimiro, Jelle Thole, Pierre Charneau, Annemieke Geluk, Jamie Triccas, Martine Gilleron, Helen Mcshane, Roberto Nisini, Steffen Stenger, Gennaro De Libero, Johan Grooten, Delia Goletti, Kris Huygen, Claire Anne Siegrist, Roland Brosch, Tom Ottenhoff, Antonio Peixoto, Peter Sander, Philip Hogarth, Camille Locht, Gregory Bancroft, Sally Sharpe, Warwick Britton, Katalin Wilkinson, Stephen Gordon, Robert Wilkinson, Michael Levin, Sang Nae Cho, Carlos Martin, January Weiner, Danielle Roordink, Simon Clark, Andre Loxton, Max Bastian, Stefan H. E. Kaufmann, Marta Romano

Risultato della ricerca: Article

15 Citazioni (Scopus)

Abstract

TBVAC2020 is a research project supported by the Horizon 2020 program of the European Commission (EC). It aims at the discovery and development of novel tuberculosis (TB) vaccines from preclinical research projects to early clinical assessment. The project builds on previous collaborations from 1998 onwards funded through the EC framework programs FP5, FP6, and FP7. It has succeeded in attracting new partners from outstanding laboratories from all over the world, now totaling 40 institutions. Next to the development of novel vaccines, TB biomarker development is also considered an important asset to facilitate rational vaccine selection and development. In addition, TBVAC2020 offers portfolio management that provides selection criteria for entry, gating, and priority settings of novel vaccines at an early developmental stage. The TBVAC2020 consortium coordinated by TBVI facilitates collaboration and early data sharing between partners with the common aim of working toward the development of an effective TB vaccine. Close links with funders and other consortia with shared interests further contribute to this goal.
Lingua originaleEnglish
pagine (da-a)1203-
Numero di pagine0
RivistaDefault journal
Volume8
Stato di pubblicazionePublished - 2017

Fingerprint

Tuberculosis Vaccines
Vaccines
Information Dissemination
Research
Patient Selection
Biomarkers

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cita questo

Caccamo, N. R., Caron, E., Meijgaarden, K. V., Nieuwenhuizen, N., Ruhwald, M., Shin, S. J., ... Romano, M. (2017). TBVAC2020: Advancing tuberculosis vaccines from discovery to clinical development. Default journal, 8, 1203-.

TBVAC2020: Advancing tuberculosis vaccines from discovery to clinical development. / Caccamo, Nadia Rosalia; Caron, Etienne; Meijgaarden, Krista Van; Nieuwenhuizen, Natalie; Ruhwald, Morten; Shin, Sung Jae; Counoupas, Claudio; Romano, Marta; Collin, Nicolas; Stylianou, Elena; Sutherland, Jayne; Williams, Ann; Andersen, Peter; Perrie, Yvonne; Ottenhoff, Tom H. M.; Aebersold, Ruedi; Barnier-Quer, Christophe; Cardona, Pere-Joan; Marinova, Dessi; Kaforou, Myrsini; Kallert, Stephanie; Tanner, Rachel; Coppola, Mariateresa; Maertzdorf, Jeroen; Aguilo, Nacho; Inchauspe, Genevieve; Christensen, Dennis; Lindenstrom, Thomas; Walzl, Gerhard; Ho, Mei Mei; Baird, Marc; Dockrell, Hazel M.; Lee, Hyejon; Tima, Hermann Giresse; Fletcher, Helen; Verreck, Frank A. W.; Choi, Ino; Drager, Nick; Patel, Brij; Marie-Ange Demoitie; Theung Long, Stephane Leung; Spertini, François; Smith, Steven; Scriba, Thomas; Vilaplana, Cris; Satti, Iman; Joosten, Simone; Aagaard, Claus; Caccamo, Nadia; Vordermeier, Martin; Pinschewer, Daniel; Vergne, Isabelle; Mascart, Francoise; Verreck, Frank; Sigal, Alex; Neyrolles, Olivier; Guilhot, Christophe; Casimiro, Danilo; Thole, Jelle; Charneau, Pierre; Geluk, Annemieke; Triccas, Jamie; Gilleron, Martine; Mcshane, Helen; Nisini, Roberto; Stenger, Steffen; De Libero, Gennaro; Grooten, Johan; Goletti, Delia; Huygen, Kris; Siegrist, Claire Anne; Brosch, Roland; Ottenhoff, Tom; Peixoto, Antonio; Sander, Peter; Hogarth, Philip; Locht, Camille; Bancroft, Gregory; Sharpe, Sally; Britton, Warwick; Wilkinson, Katalin; Gordon, Stephen; Wilkinson, Robert; Levin, Michael; Cho, Sang Nae; Martin, Carlos; Weiner, January; Roordink, Danielle; Clark, Simon; Loxton, Andre; Bastian, Max; Kaufmann, Stefan H. E.; Romano, Marta.

In: Default journal, Vol. 8, 2017, pag. 1203-.

Risultato della ricerca: Article

Caccamo, NR, Caron, E, Meijgaarden, KV, Nieuwenhuizen, N, Ruhwald, M, Shin, SJ, Counoupas, C, Romano, M, Collin, N, Stylianou, E, Sutherland, J, Williams, A, Andersen, P, Perrie, Y, Ottenhoff, THM, Aebersold, R, Barnier-Quer, C, Cardona, P-J, Marinova, D, Kaforou, M, Kallert, S, Tanner, R, Coppola, M, Maertzdorf, J, Aguilo, N, Inchauspe, G, Christensen, D, Lindenstrom, T, Walzl, G, Ho, MM, Baird, M, Dockrell, HM, Lee, H, Tima, HG, Fletcher, H, Verreck, FAW, Choi, I, Drager, N, Patel, B, Marie-Ange Demoitie, Theung Long, SL, Spertini, F, Smith, S, Scriba, T, Vilaplana, C, Satti, I, Joosten, S, Aagaard, C, Caccamo, N, Vordermeier, M, Pinschewer, D, Vergne, I, Mascart, F, Verreck, F, Sigal, A, Neyrolles, O, Guilhot, C, Casimiro, D, Thole, J, Charneau, P, Geluk, A, Triccas, J, Gilleron, M, Mcshane, H, Nisini, R, Stenger, S, De Libero, G, Grooten, J, Goletti, D, Huygen, K, Siegrist, CA, Brosch, R, Ottenhoff, T, Peixoto, A, Sander, P, Hogarth, P, Locht, C, Bancroft, G, Sharpe, S, Britton, W, Wilkinson, K, Gordon, S, Wilkinson, R, Levin, M, Cho, SN, Martin, C, Weiner, J, Roordink, D, Clark, S, Loxton, A, Bastian, M, Kaufmann, SHE & Romano, M 2017, 'TBVAC2020: Advancing tuberculosis vaccines from discovery to clinical development', Default journal, vol. 8, pagg. 1203-.
Caccamo NR, Caron E, Meijgaarden KV, Nieuwenhuizen N, Ruhwald M, Shin SJ e altri. TBVAC2020: Advancing tuberculosis vaccines from discovery to clinical development. Default journal. 2017;8:1203-.
Caccamo, Nadia Rosalia ; Caron, Etienne ; Meijgaarden, Krista Van ; Nieuwenhuizen, Natalie ; Ruhwald, Morten ; Shin, Sung Jae ; Counoupas, Claudio ; Romano, Marta ; Collin, Nicolas ; Stylianou, Elena ; Sutherland, Jayne ; Williams, Ann ; Andersen, Peter ; Perrie, Yvonne ; Ottenhoff, Tom H. M. ; Aebersold, Ruedi ; Barnier-Quer, Christophe ; Cardona, Pere-Joan ; Marinova, Dessi ; Kaforou, Myrsini ; Kallert, Stephanie ; Tanner, Rachel ; Coppola, Mariateresa ; Maertzdorf, Jeroen ; Aguilo, Nacho ; Inchauspe, Genevieve ; Christensen, Dennis ; Lindenstrom, Thomas ; Walzl, Gerhard ; Ho, Mei Mei ; Baird, Marc ; Dockrell, Hazel M. ; Lee, Hyejon ; Tima, Hermann Giresse ; Fletcher, Helen ; Verreck, Frank A. W. ; Choi, Ino ; Drager, Nick ; Patel, Brij ; Marie-Ange Demoitie ; Theung Long, Stephane Leung ; Spertini, François ; Smith, Steven ; Scriba, Thomas ; Vilaplana, Cris ; Satti, Iman ; Joosten, Simone ; Aagaard, Claus ; Caccamo, Nadia ; Vordermeier, Martin ; Pinschewer, Daniel ; Vergne, Isabelle ; Mascart, Francoise ; Verreck, Frank ; Sigal, Alex ; Neyrolles, Olivier ; Guilhot, Christophe ; Casimiro, Danilo ; Thole, Jelle ; Charneau, Pierre ; Geluk, Annemieke ; Triccas, Jamie ; Gilleron, Martine ; Mcshane, Helen ; Nisini, Roberto ; Stenger, Steffen ; De Libero, Gennaro ; Grooten, Johan ; Goletti, Delia ; Huygen, Kris ; Siegrist, Claire Anne ; Brosch, Roland ; Ottenhoff, Tom ; Peixoto, Antonio ; Sander, Peter ; Hogarth, Philip ; Locht, Camille ; Bancroft, Gregory ; Sharpe, Sally ; Britton, Warwick ; Wilkinson, Katalin ; Gordon, Stephen ; Wilkinson, Robert ; Levin, Michael ; Cho, Sang Nae ; Martin, Carlos ; Weiner, January ; Roordink, Danielle ; Clark, Simon ; Loxton, Andre ; Bastian, Max ; Kaufmann, Stefan H. E. ; Romano, Marta. / TBVAC2020: Advancing tuberculosis vaccines from discovery to clinical development. In: Default journal. 2017 ; Vol. 8. pagg. 1203-.
@article{b8331605aec9424692f2f6219ce887c5,
title = "TBVAC2020: Advancing tuberculosis vaccines from discovery to clinical development",
abstract = "TBVAC2020 is a research project supported by the Horizon 2020 program of the European Commission (EC). It aims at the discovery and development of novel tuberculosis (TB) vaccines from preclinical research projects to early clinical assessment. The project builds on previous collaborations from 1998 onwards funded through the EC framework programs FP5, FP6, and FP7. It has succeeded in attracting new partners from outstanding laboratories from all over the world, now totaling 40 institutions. Next to the development of novel vaccines, TB biomarker development is also considered an important asset to facilitate rational vaccine selection and development. In addition, TBVAC2020 offers portfolio management that provides selection criteria for entry, gating, and priority settings of novel vaccines at an early developmental stage. The TBVAC2020 consortium coordinated by TBVI facilitates collaboration and early data sharing between partners with the common aim of working toward the development of an effective TB vaccine. Close links with funders and other consortia with shared interests further contribute to this goal.",
keywords = "Bacille Calmette-Gu{\~A}{\circledC}rin, Biomarker, Clinical trial, Discovery, Immunology, Immunology and Allergy, Portfolio management, Tuberculosis, Vaccination",
author = "Caccamo, {Nadia Rosalia} and Etienne Caron and Meijgaarden, {Krista Van} and Natalie Nieuwenhuizen and Morten Ruhwald and Shin, {Sung Jae} and Claudio Counoupas and Marta Romano and Nicolas Collin and Elena Stylianou and Jayne Sutherland and Ann Williams and Peter Andersen and Yvonne Perrie and Ottenhoff, {Tom H. M.} and Ruedi Aebersold and Christophe Barnier-Quer and Pere-Joan Cardona and Dessi Marinova and Myrsini Kaforou and Stephanie Kallert and Rachel Tanner and Mariateresa Coppola and Jeroen Maertzdorf and Nacho Aguilo and Genevieve Inchauspe and Dennis Christensen and Thomas Lindenstrom and Gerhard Walzl and Ho, {Mei Mei} and Marc Baird and Dockrell, {Hazel M.} and Hyejon Lee and Tima, {Hermann Giresse} and Helen Fletcher and Verreck, {Frank A. W.} and Ino Choi and Nick Drager and Brij Patel and {Marie-Ange Demoitie} and {Theung Long}, {Stephane Leung} and Fran{\cc}ois Spertini and Steven Smith and Thomas Scriba and Cris Vilaplana and Iman Satti and Simone Joosten and Claus Aagaard and Nadia Caccamo and Martin Vordermeier and Daniel Pinschewer and Isabelle Vergne and Francoise Mascart and Frank Verreck and Alex Sigal and Olivier Neyrolles and Christophe Guilhot and Danilo Casimiro and Jelle Thole and Pierre Charneau and Annemieke Geluk and Jamie Triccas and Martine Gilleron and Helen Mcshane and Roberto Nisini and Steffen Stenger and {De Libero}, Gennaro and Johan Grooten and Delia Goletti and Kris Huygen and Siegrist, {Claire Anne} and Roland Brosch and Tom Ottenhoff and Antonio Peixoto and Peter Sander and Philip Hogarth and Camille Locht and Gregory Bancroft and Sally Sharpe and Warwick Britton and Katalin Wilkinson and Stephen Gordon and Robert Wilkinson and Michael Levin and Cho, {Sang Nae} and Carlos Martin and January Weiner and Danielle Roordink and Simon Clark and Andre Loxton and Max Bastian and Kaufmann, {Stefan H. E.} and Marta Romano",
year = "2017",
language = "English",
volume = "8",
pages = "1203--",
journal = "Default journal",

}

TY - JOUR

T1 - TBVAC2020: Advancing tuberculosis vaccines from discovery to clinical development

AU - Caccamo, Nadia Rosalia

AU - Caron, Etienne

AU - Meijgaarden, Krista Van

AU - Nieuwenhuizen, Natalie

AU - Ruhwald, Morten

AU - Shin, Sung Jae

AU - Counoupas, Claudio

AU - Romano, Marta

AU - Collin, Nicolas

AU - Stylianou, Elena

AU - Sutherland, Jayne

AU - Williams, Ann

AU - Andersen, Peter

AU - Perrie, Yvonne

AU - Ottenhoff, Tom H. M.

AU - Aebersold, Ruedi

AU - Barnier-Quer, Christophe

AU - Cardona, Pere-Joan

AU - Marinova, Dessi

AU - Kaforou, Myrsini

AU - Kallert, Stephanie

AU - Tanner, Rachel

AU - Coppola, Mariateresa

AU - Maertzdorf, Jeroen

AU - Aguilo, Nacho

AU - Inchauspe, Genevieve

AU - Christensen, Dennis

AU - Lindenstrom, Thomas

AU - Walzl, Gerhard

AU - Ho, Mei Mei

AU - Baird, Marc

AU - Dockrell, Hazel M.

AU - Lee, Hyejon

AU - Tima, Hermann Giresse

AU - Fletcher, Helen

AU - Verreck, Frank A. W.

AU - Choi, Ino

AU - Drager, Nick

AU - Patel, Brij

AU - Marie-Ange Demoitie, null

AU - Theung Long, Stephane Leung

AU - Spertini, François

AU - Smith, Steven

AU - Scriba, Thomas

AU - Vilaplana, Cris

AU - Satti, Iman

AU - Joosten, Simone

AU - Aagaard, Claus

AU - Caccamo, Nadia

AU - Vordermeier, Martin

AU - Pinschewer, Daniel

AU - Vergne, Isabelle

AU - Mascart, Francoise

AU - Verreck, Frank

AU - Sigal, Alex

AU - Neyrolles, Olivier

AU - Guilhot, Christophe

AU - Casimiro, Danilo

AU - Thole, Jelle

AU - Charneau, Pierre

AU - Geluk, Annemieke

AU - Triccas, Jamie

AU - Gilleron, Martine

AU - Mcshane, Helen

AU - Nisini, Roberto

AU - Stenger, Steffen

AU - De Libero, Gennaro

AU - Grooten, Johan

AU - Goletti, Delia

AU - Huygen, Kris

AU - Siegrist, Claire Anne

AU - Brosch, Roland

AU - Ottenhoff, Tom

AU - Peixoto, Antonio

AU - Sander, Peter

AU - Hogarth, Philip

AU - Locht, Camille

AU - Bancroft, Gregory

AU - Sharpe, Sally

AU - Britton, Warwick

AU - Wilkinson, Katalin

AU - Gordon, Stephen

AU - Wilkinson, Robert

AU - Levin, Michael

AU - Cho, Sang Nae

AU - Martin, Carlos

AU - Weiner, January

AU - Roordink, Danielle

AU - Clark, Simon

AU - Loxton, Andre

AU - Bastian, Max

AU - Kaufmann, Stefan H. E.

AU - Romano, Marta

PY - 2017

Y1 - 2017

N2 - TBVAC2020 is a research project supported by the Horizon 2020 program of the European Commission (EC). It aims at the discovery and development of novel tuberculosis (TB) vaccines from preclinical research projects to early clinical assessment. The project builds on previous collaborations from 1998 onwards funded through the EC framework programs FP5, FP6, and FP7. It has succeeded in attracting new partners from outstanding laboratories from all over the world, now totaling 40 institutions. Next to the development of novel vaccines, TB biomarker development is also considered an important asset to facilitate rational vaccine selection and development. In addition, TBVAC2020 offers portfolio management that provides selection criteria for entry, gating, and priority settings of novel vaccines at an early developmental stage. The TBVAC2020 consortium coordinated by TBVI facilitates collaboration and early data sharing between partners with the common aim of working toward the development of an effective TB vaccine. Close links with funders and other consortia with shared interests further contribute to this goal.

AB - TBVAC2020 is a research project supported by the Horizon 2020 program of the European Commission (EC). It aims at the discovery and development of novel tuberculosis (TB) vaccines from preclinical research projects to early clinical assessment. The project builds on previous collaborations from 1998 onwards funded through the EC framework programs FP5, FP6, and FP7. It has succeeded in attracting new partners from outstanding laboratories from all over the world, now totaling 40 institutions. Next to the development of novel vaccines, TB biomarker development is also considered an important asset to facilitate rational vaccine selection and development. In addition, TBVAC2020 offers portfolio management that provides selection criteria for entry, gating, and priority settings of novel vaccines at an early developmental stage. The TBVAC2020 consortium coordinated by TBVI facilitates collaboration and early data sharing between partners with the common aim of working toward the development of an effective TB vaccine. Close links with funders and other consortia with shared interests further contribute to this goal.

KW - Bacille Calmette-Guérin

KW - Biomarker

KW - Clinical trial

KW - Discovery

KW - Immunology

KW - Immunology and Allergy

KW - Portfolio management

KW - Tuberculosis

KW - Vaccination

UR - http://hdl.handle.net/10447/252195

UR - https://www.frontiersin.org/articles/10.3389/fimmu.2017.01203/full

M3 - Article

VL - 8

SP - 1203-

JO - Default journal

JF - Default journal

ER -